Not achieving the targets for children and adolescents in sub-Saharan Africa means that new infections will continue to increase and HIV related mortality will be a reality for decades to come.
The key actions needed to end AIDS are relatively clear. The question is whether every government, funder, and implementing organisations will apply them.
Long-acting cabotegravir injections once every eight weeks was better than the daily tablet used for HIV prevention.
Shutterstock
App users recognise dating apps have some risks but they’ve developed a range of strategies to help them feel safer and to better negotiate consent and safe sex.
Women walk past a mural painted to raise awareness on HIV and AIDS in Kibera slum in Nairobi, Kenya.
EPA/Dai Kurokawa
World AIDS Day is Dec. 1. With many advances in preventing and treating the disease, the disease has fallen from top of mind for many. An epidemiologist explains why that could be dangerous.
People living with HIV/AIDS all over the world are still struggling with stigma due to perceptions of the virus as dark and shameful. Here a Filipino man lights candles at a World AIDS Day even in Quezon city, Philippines in 2016.
(AP Photo/Aaron Favila)
Doctors in South Africa performed a liver transplant from an HIV-positive donor to a HIV-negative recipient. Major ethical questions came into play.
PrEP is effective as a protection against HIV – though condoms can still be used to prevent STDs. Why can’t we celebrate the idea that men can have sex without fear of death?
(Shutterstock)
Recently PrEP, an effective drug against HIV, was in the news with some concerns that gay men are no longer using condoms. But is the issue about condoms or control?
It’s unrealistic to expect everyone who is sexually active will take perfect preventative measures.
from shutterstock.com
The HIV prevention drug Truvada (PrEP) will be listed on the Pharmaceutical Benefits Scheme from this Sunday, moving Australia closer to achieving its goal of ending new HIV transmissions by 2020.
Antiretroviral treatment prevents the virus from multiplying and prolongs the lives of HIV positive people.
Thomas Mukoya/Reuters
HIV self-testing is a potential strategy to overcome access to testing. However, there are emerging concerns on the lack of counselling, possible user error and accuracy of the kits.
PrEP drugs are not a perfect solution.
Michael Moloney/Shutterstock
South Africa’s data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Trials have shown that rates of HIV infection are reduced if people not infected with HIV take anti-retrovirals - known as pre-exposure prophylaxis (PrEP). But adherence to a daily dose is a problem.
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Associate Professor, Public Health & Social Policy; Special Advisor Health Research, Office of the Vice-President Research and Innovation, University of Victoria